BGACF (BioNeutra Global) Common Stock: $5.57 Mil (As of Sep. 2024)


What is BioNeutra Global Common Stock?

BioNeutra Global BGACF Common Stock is $5.57 Mil as of Sep. 2024.

BioNeutra Global's quarterly common stock declined from Mar. 2024 ($5.58 Mil) to Jun. 2024 ($5.51 Mil) but then increased from Jun. 2024 ($5.51 Mil) to Sep. 2024 ($5.57 Mil).

BioNeutra Global's annual common stock declined from Dec. 2021 ($5.90 Mil) to Dec. 2022 ($5.56 Mil) but then increased from Dec. 2022 ($5.56 Mil) to Dec. 2023 ($5.63 Mil).

BioNeutra Global Common Stock Historical Data

* Premium members only.

The historical data trend for BioNeutra Global's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioNeutra Global Common Stock Chart

BioNeutra Global Annual Data
Trend Feb14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.73 5.90 5.90 5.56 5.63

BioNeutra Global Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.59 5.63 5.58 5.51 5.57

BioNeutra Global Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $5.57 Mil mean?
BioNeutra Global (BGACF) has a Common Stock of $5.57 Mil as of Sep. 2024. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on BioNeutra Global and its competitors.
Is BioNeutra Global's Common Stock too high?
BioNeutra Global's current Common Stock is $5.57 Mil.
How does BioNeutra Global's Common Stock compare to ARRT and BSFC?
BioNeutra Global's Common Stock of $5.57 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Consumer Packaged Goods company?
A good Common Stock depends on the Consumer Packaged Goods industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on BioNeutra Global and its competitors. BioNeutra Global's current Common Stock is $5.57 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioNeutra Global stock overvalued right now?
BioNeutra Global (BGACF) has a current Common Stock of $5.57 Mil. The current Common Stock is $5.57 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For BioNeutra Global (BGACF), the current Common Stock is $5.57 Mil as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioNeutra Global Business Description

Address 1101-1030 West Georgia Street, Vancouver, BC, CAN, V6E 2Y3
BioNeutra Global Corp is engaged in the research, development, production, and commercialization of food ingredients for neutraceutical, functional and mainstream foods, focusing on oligosaccharides. Its product portfolio provides ingredients for various food systems, that contribute to human nutrition and wellness in functional and healthy foods. Its prime product, VitaFiber IMO, is offered in both powder and syrup form. The company operates in Canada while generating sales revenue from various countries internationally. It has a single industry segment, manufacturing and trading of products. The majority of the revenue is derived from the United States.